Switzerland Receives First Hyperthermia Cancer Treatment System From BSD Medical

SALT LAKE CITY--(HSMN NewsFeed)--BSD Medical Corp. (AMEX:BSM ) today announced the installation of the first BSD-500 hyperthermia cancer therapy system in Switzerland at the Department of Radiation Oncology of Kantonsspital Aarau. The hospital joins BSD’s growing family of prestigious global customers with the purchase and installation of the new hyperthermia therapy system. The BSD-500 will be used to increase the Department’s cancer therapy technology, particularly in treating advanced and recurrent cancer patients. It delivers hyperthermia through the use of microwave energy, helping to address the limitations of radiation therapy.

Full text >>